AIF seeks to become the the investment and innovation arm for autism spectrum disorder (ASD), neurodevelopmental disorders, mental health issues, and complex chronic conditions.


AIF’s bold mission is to revolutionize the status quo for diagnosing, treating, and living with autism spectrum disorder (ASD), neurodevelopment disorders, mental health issues, and complex chronic conditions through a venture capital model that helps accelerate developing and delivering emerging technologies, translational science, and innovative services to empower individuals to reach their full potential.


At AIF, we identify unmet needs across the continuum of ASD and related conditions and deploy venture capital to invent, develop, and fuel solutions that address those needs.